Free Trial

This company recently went public with an IPO on Thursday, September 11th 2025. They issued 19,000,000 shares at $15.00 per share. We will continue to update data for LBRX as it becomes available.

LB Pharmaceuticals (LBRX) SEC Filings & 10K Form

$14.90 -1.12 (-6.99%)
As of 04:00 PM Eastern

Recent LB Pharmaceuticals SEC Filings

DateFilerForm TypeView
09/19/2025
3:47 PM
LB Pharmaceuticals (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SCHEDULE 13G
09/19/2025
3:30 PM
Deep Track Capital, LP (Filed by)
LB Pharmaceuticals (Subject)
Form SCHEDULE 13D
09/18/2025
3:24 PM
LB Pharmaceuticals (Subject)
TCG Crossover GP II, LLC (Filed by)
Form SCHEDULE 13G
09/16/2025
5:07 PM
Deep Track Special Opportunities Fund, LP (Reporting)
LB Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/16/2025
5:09 PM
Deep Track Biotechnology Master Fund, Ltd. (Reporting)
Deep Track Capital, LP (Reporting)
KROIN DAVID (Reporting)
LB Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2025
3:15 PM
LB Pharmaceuticals (Issuer)
Nussbaum Ran (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2025
3:15 PM
LB Pharmaceuticals (Issuer)
Pontifax Management 4 G.P. Ltd. (0001726334) (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2025
2:46 PM
Belldegrun Arie (Reporting)
LB Pharmaceuticals (Issuer)
Vida Ventures GP III, L.L.C. (Reporting)
Vida Ventures III, L.P. (Reporting)
Vida Ventures III-A, L.P. (Reporting)
Vida Ventures Management Co. LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2025
5:25 PM
LB Pharmaceuticals (Issuer)
Turner Heather D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2025
5:25 PM
LB Pharmaceuticals (Issuer)
Soffer Gad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2025
5:25 PM
Eramo Anna (Reporting)
LB Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2025
5:25 PM
LB Pharmaceuticals (Issuer)
Silva Richard Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2025
5:25 PM
Garland J. Scott (Reporting)
LB Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2025
5:25 PM
LB Pharmaceuticals (Issuer)
Nussbaum Ran (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2025
5:25 PM
LB Pharmaceuticals (Issuer)
PRENSKY ZACHARY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2025
5:25 PM
LB Pharmaceuticals (Issuer)
RUFFOLO ROBERT R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2025
5:25 PM
Kane William P Jr (Reporting)
LB Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2025
5:25 PM
LB Pharmaceuticals (Issuer)
Luse Rebecca (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2025
5:25 PM
Hemrajani Rekha (Reporting)
LB Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2025
3:06 PM
LB Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2025
5:30 AM
LB Pharmaceuticals (Filer)
Form 424B4
09/12/2025
5:30 AM
LB Pharmaceuticals (Filer)
Form 424B4
09/11/2025
5:38 PM
LB Pharmaceuticals (Issuer)
Silva Richard Anthony (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/11/2025
10:05 AM
LB Pharmaceuticals (Issuer)
Pontifax Management 4 G.P. Ltd. (0001726334) (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/11/2025
8:19 AM
LB Pharmaceuticals (Issuer)
Nussbaum Ran (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/10/2025
11:15 PM
LB Pharmaceuticals (Filer)
Form EFFECT
09/10/2025
7:39 PM
Belldegrun Arie (Reporting)
LB Pharmaceuticals (Issuer)
Vida Ventures GP III, L.L.C. (Reporting)
Vida Ventures III, L.P. (Reporting)
Vida Ventures III-A, L.P. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/10/2025
7:30 PM
LB Pharmaceuticals (Filer)
Form S-1MEF
09/10/2025
6:34 PM
LB Pharmaceuticals (Issuer)
Soffer Gad (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/10/2025
6:21 PM
LB Pharmaceuticals (Issuer)
PRENSKY ZACHARY (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/10/2025
6:22 PM
Garland J. Scott (Reporting)
LB Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/10/2025
6:24 PM
Kane William P Jr (Reporting)
LB Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/10/2025
6:30 PM
Hemrajani Rekha (Reporting)
LB Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/10/2025
6:31 PM
LB Pharmaceuticals (Issuer)
Turner Heather D (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/10/2025
6:32 PM
LB Pharmaceuticals (Issuer)
Luse Rebecca (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/10/2025
6:33 PM
Deep Track Biotechnology Master Fund, Ltd. (Reporting)
Deep Track Capital, LP (Reporting)
KROIN DAVID (Reporting)
LB Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/10/2025
6:19 PM
Eramo Anna (Reporting)
LB Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/10/2025
6:20 PM
LB Pharmaceuticals (Issuer)
RUFFOLO ROBERT R (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/10/2025
10:56 AM
LB Pharmaceuticals (Filer)
Form CERT
09/09/2025
6:30 AM
LB Pharmaceuticals (Filer)
Form 8-A12B
09/08/2025
9:03 AM
LB Pharmaceuticals (Filer)
LB Pharmaceuticals (Filer)
Form S-1/A
08/22/2025
3:49 PM
LB Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:LBRX) was last updated on 9/23/2025 by MarketBeat.com Staff
From Our Partners